Researchers at the USC Center for Personalized Brain Health have identified a way to shut down brain inflammation in people carrying the APOE4 gene variant—the strongest genetic risk factor for late-onset Alzheimer's—before cognitive decline begins. Using artificial intelligence and small-molecule targeting, they aim to inhibit an overactive enzyme called cPLA2, which triggers chronic inflammation years before memory loss appears.
The Research
Led by Dr. Hussein Yassine, MD, director of the USC Center for Personalized Brain Health (CPBH), the team zeroed in on elevated levels of calcium-dependent phospholipase A2 (cPLA2) in APOE4 carriers who later develop dementia. By developing small-molecule therapies that selectively inhibit cPLA2, they hope to quell inflammation while leaving healthy cellular functions untouched.
A $3 million gift from the Norman and Mary Pattiz Foundation to the Keck School of Medicine of USC is accelerating this work. The fund supports AI-driven drug discovery to rapidly screen thousands of small molecules for those that can cross the blood-brain barrier and block cPLA2. It also establishes a high-risk early-detection registry, pairing APOE4 genetic data with cardiovascular risk factors to recruit candidates for clinical trials.
Additionally, neuropathologist Dr. Anne Hiniker will audit more than 1,100 human brain tissue samples from the USC ADRC Neuropathology Core to map microscopic inflammatory markers. Recruitment will tap two existing USC networks: GeneScreen (a genetic risk registry) and CPBH SPARK (tracking lifestyle effects on cognitive aging).
Why It Matters
For the estimated 25% of the population carrying at least one APOE4 allele, this research offers a potentially powerful preventive approach. Currently, no treatments target the inflammatory cascade that precedes Alzheimer's symptoms. If the cPLA2 inhibition pathway proves safe and effective in humans, it could lead to a drug that high-risk individuals take years before any cognitive changes appear—essentially turning off the inflammatory fuse before it reaches the brain's memory centers.
What You Can Do
While this therapy is still in development, you can reduce your general brain inflammation risk today. Key lifestyle factors include maintaining a heart-healthy diet (Mediterranean diet is strongly linked to lower inflammation), regular aerobic exercise, managing blood pressure and cholesterol, and avoiding smoking. If Alzheimer's runs in your family, consider genetic counseling to learn your APOE status and discuss monitoring options with a healthcare provider.
Source: Neuroscience News
Curious about your own brain? Take our free adaptive IQ test or try 306 brain training levels.
